Biochemical studies of cardiac hypertrophy

Biochemical studies of cardiac hypertrophy

Bibliographic Details
Main Author:	Paternostro, Giovanni
Published:	University of Oxford 1996
Subjects:	572 Heart failure
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.337538

Similar Items

Calcium handling and gene expression in cardiac hypertrophy and following ramipril treatment in rat
by: Boateng, Samuel
Published: (1998)

HB-EGF, Transactivation, and Cardiac Hypertrophy
by: Seiji Takashima, et al.
Published: (2007-03-01)

Studies on the biochemical mechanisms involved in the initiation of cardiac hypertrophy /
by: Berry, Arnold J.
Published: (1971)

Editorial: Cardiac Hypertrophy: From Compensation to Decompensation and Pharmacological Interventions
by: Ya Liu, et al.
Published: (2021-04-01)

Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis
by: Chaoliang Tang, et al.
Published: (2020-09-01)

Magnetic resonance spectroscopy studies of the myocardium under physiological and pathological conditions
by: Pritchard, Ronald Douglas
Published: (1996)

Hispidulin Attenuates Cardiac Hypertrophy by Improving Mitochondrial Dysfunction
by: Yan Wang, et al.
Published: (2020-11-01)

Brain renin angiotensin system in cardiac hypertrophy and failure
by: Luciana eCampos, et al.
Published: (2012-01-01)

Cardiac‐specific ablation of glutaredoxin 3 leads to cardiac hypertrophy and heart failure
by: Jimmonique Donelson, et al.
Published: (2019-04-01)

Functional, morphologic, and biochemical pathology of spontaneous and experimental right ventricular hypertrophy and congestive heart failure in the dog /
by: Bishop, Sanford Parsons
Published: (1968)

Role of microRNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
by: De-li Dong, et al.
Published: (2011-06-01)

Angiogenic Endothelial Cell Signaling in Cardiac Hypertrophy and Heart Failure
by: Rajinikanth Gogiraju, et al.
Published: (2019-03-01)

Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure
by: Gabriele G. Schiattarella, et al.
Published: (2018-05-01)

Role of Irisin in Myocardial Infarction, Heart Failure, and Cardiac Hypertrophy
by: Ming-Yun Ho, et al.
Published: (2021-08-01)

TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
by: Andrea Grund, et al.
Published: (2019-10-01)

The role and molecular mechanism of FoxO1 in mediating cardiac hypertrophy
by: Wei Yu, et al.
Published: (2020-12-01)

Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
by: Einar Sjaastad Nordén, et al.
Published: (2021-04-01)

Dual‐Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1
by: Jing Zhao, et al.
Published: (2021-02-01)

Identification of Lactate as a Cardiac Protectant by Inhibiting Inflammation and Cardiac Hypertrophy Using a Zebrafish Acute Heart Failure Model
by: Elijah R. Haege, et al.
Published: (2021-03-01)

Patterns of ion channel expression in cardiac hypertrophy
by: Sayeed, Rana Ahmed
Published: (2004)

TRANSCRIPTIONAL REGULATION OF CARDIAC HYPERTROPHY AND HEART FAILURE
by: XU, JIAN
Published: (2006)

Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart
by: Ajit Magadum, et al.
Published: (2021-05-01)

Cardiac dyssynchrony in heart failure
Published: (2015)

Receptor subtypes and associated mechanisms in the stimulation of ventricular cell hypertrophy by angiotensin II and endothelin-1
by: Cullen, John Patrick
Published: (1999)

The role of protein kinases in the development of cardiac hypertrophy
by: Decock, Juliette Brigitte Joelle
Published: (1997)

Protective Effects of Thyroid Hormone Deprivation on Progression of Maladaptive Cardiac Hypertrophy and Heart Failure
by: Helena Kerp, et al.
Published: (2021-07-01)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
by: Alessandro Giollo, et al.
Published: (2021-06-01)

Pressure Overload-induced Cardiac Hypertrophy Varies According to Different Ligation Needle Sizes and Body Weights in Mice
by: Zhen Jia, et al.

Assessment of Relationship between Galectin-3 and Biochemical Parameters in Peritoneal Dialysis Patients with Left Ventricular Hypertrophy
by: Sultan Alouffi, et al.
Published: (2020-08-01)

Transport of monocarboxylates across the cardiac sarcolemmal membrane
by: Wang, Xuemin
Published: (1994)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
by: Nicholas Stafford, et al.
Published: (2020-10-01)

PHARMACOLOGICAL ASPECTS OF CARDIAC HYPERTROPHY
by: Womble, Jacqueline Ruth
Published: (1981)

mir15a/mir16‐1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy
by: Hongchang Guo, et al.
Published: (2020-12-01)

Transcriptomic Validation of the Protective Effects of Aqueous Bark Extract of Terminalia arjuna (Roxb.) on Isoproterenol-Induced Cardiac Hypertrophy in Rats
by: Gaurav Kumar, et al.
Published: (2019-12-01)

Cardiac rehabilitation in chronic heart failure
by: Romualdo Belardinelli
Published: (2016-11-01)

Biochemical algorithms of early diagnostic of metabolic remodeling and cardiac hypertrophy in patients with diabetic mellitus and chronic heart failure cause by ischemic heart disease
by: O. P. Donetskaya, et al.
Published: (2019-08-01)

Role of PI3-Kinase in Angiotensin II-Induced Cardiac Hypertrophy: Class I Versus Class III
by: Tiecheng Zhong, et al.
Published: (2021-02-01)

Myocardial hypertrophy reduces transmural variation in mitochondrial function
by: Premi eHaynes, et al.
Published: (2014-05-01)

MicroRNA basis of physiological hypertrophy
by: Siyi eFu, et al.
Published: (2013-11-01)

Biochemical mechanisms of cellular damage in the isolated rat heart
by: Daniels, Stephanie
Published: (1990)